Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,470 | -19,013 | -14,524 | -7,338 | -16,902 |
| Depreciation Amortization | 1,592 | 910 | 625 | 348 | 1,504 |
| Accounts receivable | -1,222 | -905 | -2,245 | 645 | 209 |
| Accounts payable and accrued liabilities | 540 | 1,523 | -173 | 1,518 | 932 |
| Other Working Capital | -1,338 | -1,053 | -2,212 | 3,096 | 1,869 |
| Other Operating Activity | 5,356 | 3,251 | 5,621 | 502 | 880 |
| Operating Cash Flow | $-17,542 | $-15,287 | $-12,908 | $-1,229 | $-11,508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,676 | -997 | -714 | -220 | -1,529 |
| Purchase Of Investment | -71,379 | -60,542 | -57,712 | -21,869 | N/A |
| Sale Of Investment | 29,966 | 13,492 | 3,490 | 0 | N/A |
| Purchase Sale Intangibles | -2,000 | -2,000 | N/A | N/A | N/A |
| Other Investing Activity | -2,021 | -2,021 | -21 | 0 | 196 |
| Investing Cash Flow | $-45,110 | $-50,068 | $-54,957 | $-22,089 | $-1,333 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | 5,000 | 5,000 | 3,125 |
| Debt Repayment | -12,867 | -11,390 | -9,956 | -8,572 | N/A |
| Common Stock Issued | 78,234 | 77,822 | 77,188 | 77,012 | 39 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 633 |
| Financing Cash Flow | $70,367 | $71,432 | $72,232 | $73,440 | $3,797 |
| Exchange Rate Effect | 115 | 81 | 39 | -14 | 165 |
| Beginning Cash Position | 5,723 | 5,723 | 5,723 | 5,723 | 14,602 |
| End Cash Position | 13,553 | 11,881 | 10,129 | 55,831 | 5,723 |
| Net Cash Flow | $7,830 | $6,158 | $4,406 | $50,108 | $-8,879 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,542 | -15,287 | -12,908 | -1,229 | -11,508 |
| Capital Expenditure | -1,676 | -997 | -714 | -220 | -1,539 |
| Free Cash Flow | -19,218 | -16,284 | -13,622 | -1,449 | -13,047 |